MYO logo

MYOMO INC

MYONYSE AMERICAN
๐Ÿ† #4017 by market capEarnings Nov 9US Equity
$1.52โ–ฒ $0.00 (+0.33%)
Live
1hโ–ฒ 1.7%
24hโ–ฒ 0.3%
7dโ–ฒ 43.6%
14dโ–ฒ 58.6%
30dโ–ฒ 37.7%
1yโ–ฒ 41.6%
๐ŸฆMarket Cap
$59M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+25.7%
High Growth
๐Ÿ“ŠGross Margin
68.3%
High
๐Ÿ’ตFCF Margin
-20.4%
Thin
โš–๏ธP/S Ratio
1.4x
Cheap
Otter Score
59
Weak

Trading Snapshot

Day Range
$1.50 โ€“ $1.53
52-Week Range
$0.61 โ€“ $1.59
Volume
$4.20B
Avg Volume
$4.46B
Shares Outstanding
38.6M
Next Earnings
Sep 6, 2026

Fundamentals Snapshot

Annual Revenue
$41M
Last Q Revenue
$12M
P/E Ratio
-4.5
P/S Ratio
1.4x
EPS (TTM)
$-0.34
Dividend Yield
0.00%

Why Investors Own MYO

  • โœ“High-growth profile โ€” revenue up +55.0% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 27% gross margin and 6% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$41Mโ–ฒ +53.6% YoY
Gross Margin (TTM)
27.2%โ–ฒ +0.4% YoY
Operating Income (TTM)
$5Mโ–ฒ +53.6% YoY
Free Cash Flow (TTM)
$3Mโ–ฒ +53.6% YoY

About MYOMO INC

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
59/100

Analyst Ratings

โ“˜
Consensus
Buy
9 analysts
Strong Buy1
Buy7
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates